Phase II study of low-dose paclitaxel with timed thoracic radiotherapy (TTR) followed by gemcitabine and carboplatin consolidation in patients with unresectable stage III non-small cell lung cancer (NSCLC): NCT 00449657.
J. Zhang
No relevant relationships to disclose
S. M. Russo
No relevant relationships to disclose
H. A. Gay
No relevant relationships to disclose
T. Parent
No relevant relationships to disclose
Z. Nelson
No relevant relationships to disclose
S. Eubanks
No relevant relationships to disclose
P. R. Walker
No relevant relationships to disclose